5.26
price up icon4.78%   0.24
 
loading
Schlusskurs vom Vortag:
$5.02
Offen:
$5
24-Stunden-Volumen:
4.56M
Relative Volume:
1.08
Marktkapitalisierung:
$1.23B
Einnahmen:
$251.85M
Nettoeinkommen (Verlust:
$-72.58M
KGV:
-16.78
EPS:
-0.3134
Netto-Cashflow:
$-63.80M
1W Leistung:
+9.24%
1M Leistung:
+1.35%
6M Leistung:
-8.84%
1J Leistung:
-16.64%
1-Tages-Spanne:
Value
$4.8918
$5.28
1-Wochen-Bereich:
Value
$4.54
$5.28
52-Wochen-Spanne:
Value
$4.02
$9.33

Ardelyx Inc Stock (ARDX) Company Profile

Name
Firmenname
Ardelyx Inc
Name
Telefon
510-745-7047
Name
Adresse
34175 ARDENWOOD BLVD., FREMONT, CA
Name
Mitarbeiter
267
Name
Twitter
@ardelyx
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
ARDX's Discussions on Twitter

Vergleichen Sie ARDX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ARDX
Ardelyx Inc
5.26 1.23B 251.85M -72.58M -63.80M -0.3134
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Ardelyx Inc Stock (ARDX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-07 Fortgesetzt Ladenburg Thalmann Buy
2025-03-04 Eingeleitet BTIG Research Buy
2024-11-11 Herabstufung H.C. Wainwright Buy → Neutral
2024-07-02 Herabstufung Piper Sandler Overweight → Neutral
2024-04-05 Eingeleitet Leerink Partners Outperform
2023-12-18 Eingeleitet Raymond James Strong Buy
2023-09-07 Eingeleitet H.C. Wainwright Buy
2023-08-25 Hochstufung Cantor Fitzgerald Neutral → Overweight
2023-03-03 Hochstufung Wedbush Neutral → Outperform
2022-11-17 Hochstufung Piper Sandler Neutral → Overweight
2022-05-06 Herabstufung Cantor Fitzgerald Overweight → Neutral
2021-12-01 Hochstufung Ladenburg Thalmann Neutral → Buy
2021-10-14 Herabstufung Ladenburg Thalmann Buy → Neutral
2021-07-21 Herabstufung Jefferies Buy → Hold
2021-07-20 Herabstufung Piper Sandler Overweight → Neutral
2021-07-20 Herabstufung Wedbush Outperform → Neutral
2021-03-23 Eingeleitet Wedbush Outperform
2021-01-06 Eingeleitet Cantor Fitzgerald Overweight
2020-10-20 Fortgesetzt Citigroup Buy
2020-02-18 Fortgesetzt Jefferies Buy
2020-02-12 Eingeleitet Citigroup Buy
2020-02-10 Eingeleitet Cowen Outperform
2019-04-08 Eingeleitet Piper Jaffray Overweight
2018-08-24 Eingeleitet Jefferies Buy
2018-03-19 Fortgesetzt Leerink Partners Outperform
2017-11-29 Bestätigt Citigroup Buy
2017-11-22 Bestätigt Ladenburg Thalmann Buy
2017-10-17 Fortgesetzt Leerink Partners Outperform
2016-03-31 Eingeleitet Ladenburg Thalmann Buy
2016-03-09 Eingeleitet Cantor Fitzgerald Buy
2016-03-03 Eingeleitet Citigroup Buy
Alle ansehen

Ardelyx Inc Aktie (ARDX) Neueste Nachrichten

pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 24, 2025

Ardelyx Announces Three Abstracts Accepted For Poster Presentations At Digestive Disease Week 2025 Conference - marketscreener.com

Apr 24, 2025
pulisher
Apr 24, 2025

Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference - The Manila Times

Apr 24, 2025
pulisher
Apr 24, 2025

Groundbreaking IBSRELA Pediatric Safety Data Headlines 3 New Studies at Digestive Disease Week 2025 - Stock Titan

Apr 24, 2025
pulisher
Apr 23, 2025

(ARDX) Proactive Strategies - news.stocktradersdaily.com

Apr 23, 2025
pulisher
Apr 19, 2025

Lobbying Update: $620,000 of ARDELYX INC. lobbying was just disclosed - Nasdaq

Apr 19, 2025
pulisher
Apr 17, 2025

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025 - The Manila Times

Apr 17, 2025
pulisher
Apr 17, 2025

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025 | ARDX Stock News - GuruFocus

Apr 17, 2025
pulisher
Apr 17, 2025

Ardelyx, Inc. Schedules Conference Call to Discuss Q1 2025 Financial Results and Business Update - Nasdaq

Apr 17, 2025
pulisher
Apr 16, 2025

Is Ardelyx Inc. (NASDAQ:ARDX) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey

Apr 16, 2025
pulisher
Apr 16, 2025

April 2025's Top Penny Stocks To Watch - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

13 Best Biotech Penny Stocks to Buy According to Hedge Funds - Insider Monkey

Apr 15, 2025
pulisher
Apr 15, 2025

Stride Announces Date for Third Quarter Fiscal Year 2025 Earnings Call - The Globe and Mail

Apr 15, 2025
pulisher
Apr 11, 2025

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings - The Manila Times

Apr 11, 2025
pulisher
Apr 10, 2025

Ardelyx reveals new findings on CKD treatment XPHOZAH at NKF event - Investing.com Canada

Apr 10, 2025
pulisher
Apr 10, 2025

Ardelyx reveals new findings on CKD treatment XPHOZAH at NKF event By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Ontario Teachers' Appoints Terry Hickey as Chief Technology Officer - The Globe and Mail

Apr 10, 2025
pulisher
Apr 10, 2025

Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

Breakthrough: New Analysis Reveals Better Outcomes for First-in-Class Kidney Drug XPHOZAH - Stock Titan

Apr 10, 2025
pulisher
Apr 08, 2025

Ardelyx CEO Michael Raab sells $191k in stock - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Ardelyx CEO Michael Raab sells $191k in stock By Investing.com - Investing.com UK

Apr 08, 2025
pulisher
Apr 07, 2025

Ardelyx stock hits 52-week low at $4.29 amid challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Ardelyx stock hits 52-week low at $4.29 amid challenges - Investing.com Australia

Apr 07, 2025
pulisher
Apr 06, 2025

How To Trade (ARDX) - news.stocktradersdaily.com

Apr 06, 2025
pulisher
Apr 06, 2025

Levi's (LEVI) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Apr 06, 2025
pulisher
Apr 03, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx, Inc. LawsuitARDX - ACCESS Newswire

Apr 03, 2025
pulisher
Apr 02, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx LawsuitARDX - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 01, 2025

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings - The Manila Times

Apr 01, 2025
pulisher
Mar 31, 2025

First-in-Class Kidney Disease Drug XPHOZAH Reveals Breakthrough Clinical Results - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Commit To Purchase Ardelyx At $4, Earn 20.5% Annualized Using Options - Nasdaq

Mar 31, 2025
pulisher
Mar 28, 2025

Institutional owners may take dramatic actions as Ardelyx, Inc.'s (NASDAQ:ARDX) recent 6.4% drop adds to one-year losses - simplywall.st

Mar 28, 2025
pulisher
Mar 27, 2025

How to Take Advantage of moves in (ARDX) - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 25, 2025

Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire

Mar 25, 2025
pulisher
Mar 20, 2025

Ardelyx Requests to Dismiss Class Action Filed by Investors - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - Marketscreener.com

Mar 20, 2025
pulisher
Mar 19, 2025

ARDELYX INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Mar 19, 2025
pulisher
Mar 17, 2025

Trading (ARDX) With Integrated Risk Controls - news.stocktradersdaily.com

Mar 17, 2025
pulisher
Mar 13, 2025

Ardelyx honors inaugural Derek Forfang award winners By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth By Investing.com - Investing.com UK

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx honors inaugural Derek Forfang award winners - Investing.com India

Mar 13, 2025

Finanzdaten der Ardelyx Inc-Aktie (ARDX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):